Angiotensin Converting Enzyme Gene Polymorphism in Healthy Thais and Patients with Non-Insulin Dependent Diabetes Mellitus

Journal of the Medical Association of Thailand

Volumn 80, Issue 12, 1997, Pages

  Nitiyanant, Wannee ^a   Sriussadaporn, Sutin ^a   Ploybutr, Sirirat ^a   Watanakejorn, Praneet ^a   Tunlakit, Monchaya ^a   Bejrachandra, Sasitorn ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 2442693295     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Schunkert H, Hense H-W, Holmer SR, et al. Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N Engl J Med 1994; 330: 1634-8.
2. Chiu KC, Moskowitz DW, Permutt MA. The role of the angiotensin-1 converting enzyme gene in the pathogenesis of non-insulin-dependent diabetes mellitus. In : Schwartz CJ, Born GVR (eds). New horizons in diabetes mellitus and cardiovascular disease. London : Current Science Ltd, 1995; 28-33.
3. Ruiz J, Blanche H, Cohen N, et al. Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary heart disease in non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA 1994; 91: 3662-5.
4. Doi Y, Yoshizumi H, Yoshinari M, et al. Association between a polymorphism in the angiotensin-converting enzyme gene and microvascular complications in Japanese patients with NIDDM. Diabetologia 1996; 39: 97-102.
5. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin 1-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86: 1343-6.
6. Tarnow L, Cambien F, Rossing P, et al. Lack of relationship between an insertion/deletion polymorphism in the angiotensin 1-converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients. Diabetes 1995; 44: 489-94.
7. Ohno T, Kawasu S, Tomono S. Association analyses of the polymorphisms cf angiotensin-converting enzyme and angiotensinogen genes with diabetic nephropathy in Japanese non-insulin-dependent diabetics. Metab Clin Exp 1996; 45: 218-22.
8. Wilson PWF, Kannel WB. Epidemiology of hyperglycemia and atherosclerosis. In : Ruderman N, Williamson J, Brownlee M (eds). Hyperglycemia, diabetes and vascular disease. New York : Oxford University Press, 1992: 21-9.
9. Rigat B, Hubert C, Corvol P, Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP 1) (dipeptidyl carboxypeptidase 1). Nucl Acids Res 1992; 20: 1433.
10. Sritara P, Sura T, Thaisethawatana P, et al. ACE gene and angiotensin II receptor gene polymorphism in Thai population. Abstract, 28th Annual Meeting of the Heart Association of Thailand, Bangkok 1996: 15.
11. Cambien F, Poirier O. Lecerf L, et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992; 359: 641-4.
12. Chowdhury TA, Dronsfield MJ, Kumar S, et al. Examination of two genetic polymorphisms within the renin-angiotensin system : no evidence for an association with nephropathy in IDDM. Diabetologia 1996; 39: 1108-14.
13. Lindpaintner K, Pfeffer MA. Kreutz R, et al. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med 1995; 332: 706-11.
14. Shanmugam V, Sell KW, Saha BK. Mistyping ACE Heterozygotes. PCR Methods Appl 1993; 3: 120-1.
15. Kodama J, Katayama S, Tanaka K, et al. Effect of captopril on glucose concentration. Possible role of augmented postprandial forearm blood flow. Diabetes Care 1990; 13: 1109-11.
16. Santoro D, Natali A, Galvan AQ, et al. Glucose tolerance and insulin secretion in essential hypertension after treatment with an angiotensin converting enzyme inhibitor. J Hypertens 1991; 9 (Suppl): S406-7.
17. Fujisawa T, Ueda H, Ikegami H, et al. Angiotensin 1-converting enzyme gene polymorphism is associated with myocardial infarction, but not with retinopathy or nephropathy, in NIDDM. Diabetes Care 1995; 18: 983-5.
18. Keavney BD, Dudley CRK, Stratton IM, et al. UK Prospective Diabetes Study (UKPDS) 14: association of angiotensin-converting enzyme insertion/deletion polymorphism with myocardial infarction in NIDDM. Diabetologia 1995, 38: 948-52.
19. Tarnow L, Cambien F, Rossing P, et al. Insertion/ deletion polymorphism in the angiotensin-1-converting enzyme gene is associated with coronary heart disease in IDDM patients with diabetic nephropathy. Diabetologia 1995; 38: 798-803.
20. Nagi DK, Mansfield MW, Stickland MH, Grant PJ. Angiotensin converting enzyme (ACE) insertion/ deletion (L/D) polymorphism, and diabetic retinopathy in subjects with IDDM and NIDDM. Diabetic Med 1995; 12: 997-1001.